Dr Lauren Marie Weinand, MD | |
2920 N 4th St, Flagstaff, AZ 86004-1816 | |
(928) 522-9400 | |
Not Available |
Full Name | Dr Lauren Marie Weinand |
---|---|
Gender | Female |
Speciality | Student In An Organized Health Care Education/training Program |
Location | 2920 N 4th St, Flagstaff, Arizona |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1396388740 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207Q00000X | Family Medicine | 2019038350 (Missouri) | Secondary |
390200000X | Student In An Organized Health Care Education/training Program | R78331 (Arizona) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Lauren Marie Weinand, MD Po Box 3630, Flagstaff, AZ 86003-3630 Ph: (928) 522-9879 | Dr Lauren Marie Weinand, MD 2920 N 4th St, Flagstaff, AZ 86004-1816 Ph: (928) 522-9400 |
News Archive
Research from an investigator at Rutgers Cancer Institute of New Jersey and colleagues from other facilities across the country, shows a social-cognitive intervention designed for parents of children undergoing a stem cell transplant had beneficial effects in reducing caregiver distress during the hospitalization period as compared with current best-practice psychosocial care.
In a paper uploaded to the preprint server medRxiv*, antibodies against both the spike protein and nucleocapsid proteins of SARS-CoV-2 are measured in over 3,000 volunteers, six months following the initiation of the vaccination scheme in Geneva, Switzerland.
Bacterin International Holdings, Inc., a leader in the development of revolutionary bone graft material and anti-infective coatings for medical applications, expects to report its seventh consecutive quarter of record revenue growth.
SELEX is a rapid, efficient, and iterative high-throughput method for screening large libraries of molecules to identify those with the potential to be developed as drug compounds or research tools. Advances in SELEX technology that have enabled screening in live cells, called Cell-SELEX, are explored in a comprehensive Review article published in BioResearch Open Access, a bimonthly peer-reviewed open access journal from Mary Ann Liebert, Inc.
› Verified 1 days ago